Full Text View
Tabular View
No Study Results Posted
Related Studies
Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study
This study has been completed.
Study NCT01348880   Information provided by Bayer

First Received on May 4, 2011.   Last Updated on May 10, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Erectile Dysfunction
More general conditions related to this trial
Genital Diseases, Male
Mental Disorders
Sexual and Gender Disorders
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological
Interventions listed in this trial
Placebo
Additional drug interventions recognized in this trial
Nifedipine
Vardenafil
More general drug interventions related to this trial
Calcium Channel Blockers
Cardiovascular Agents
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Tocolytic Agents
Vasodilator Agents
Sponsors listed in this trial
Bayer
GlaxoSmithKline
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services